Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Ferumoxytol vs Oral Ferrous Sulfate for IDA Post-Bariatric Surgery
NCT03777514Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Aug 2019
- Primary completion
- Oct 2021
- Modality
- Nanoparticles, Small Molecules
01
Overview
Randomised, double-blind trial of ferumoxytol in iron deficiency anemia (IDA), sponsored by Johns Hopkins University. Primary endpoint: Clinical Global Impression - 2 at 6 weeks. Planned start Aug 2019; status: withdrawn.
02
Drugs
ferumoxytol
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT03777514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03777514.